Nkarta Stock

Nkarta Dividend 2024

Nkarta Dividend

0 USD

Nkarta Dividend yield

Ticker

NKTX

ISIN

US65487U1088

WKN

A2P797

How much dividend does Nkarta 2024 pay?

According to the latest status from December 2024, Nkarta paid a total of 0 USD per share in dividends within the last 12 months. With the current Nkarta price of 2.72 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Nkarta Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Nkarta Dividend Safe?

Nkarta has been increasing the dividend for 0 years.

Over the past 6 years, Nkarta has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Nkarta's Dividend Distributions

Nkarta’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Nkarta's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Nkarta's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Nkarta’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Nkarta Aktienanalyse

What does Nkarta do?

Nkarta Inc is a biopharmaceutical company based in South San Francisco, California. The company was founded in 2015 by Dr. Raphael Rousseau (CEO) to develop a groundbreaking new therapy for cancer patients. The business model of Nkarta is based on the development of novel CAR-T cell therapies. These are a special type of immunotherapy in which the patient's own immune cells are genetically modified and used to target tumor cells. Unlike conventional chemotherapy or radiation, which can also attack healthy cells, CAR-T cell therapies specifically target cancer cells while sparing the surrounding healthy tissue. Nkarta is divided into various business areas, including research and development of new therapies, manufacturing and production of CAR-T cells, and clinical trials and approval processes for broad application. One of Nkarta's key products is NKR-2, a CAR-T cell therapy based on natural killer cells. These cells have high activity against cancer cells and can respond quickly to threats. NKR-2 differentiates itself from other therapies by its ability to be effective even at low concentrations. This means that fewer cells are needed and the risk of unwanted side effects is reduced. Nkarta is also working on other projects, including NKX101, which specializes in treating solid tumors, and Voretigene Neparvovec, a gene therapy for the rare hereditary retinal disease. In 2020, Nkarta entered into a partnership with CRISPR Therapeutics to explore the joint potential of CRISPR gene editing and CAR-T cell therapy. The collaboration aims to improve the precision and effectiveness of CAR-T cell therapies and ultimately increase the chances of a cure for cancer patients. Overall, Nkarta has had an impressive success story in recent years. The company has raised several million dollars in funding and continues to expand. The groundbreaking technology of CAR-T cell therapies is promising and has the potential to have a sustainable impact on healthcare. With Nkarta at the forefront, the future could look much more hopeful for cancer patients. Nkarta is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Nkarta stock

How much dividend does Nkarta pay?

Over the past 12 months, Nkarta paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nkarta is expected to pay a dividend of 0 USD.

What is the dividend yield of Nkarta?

The current dividend yield of Nkarta is .

When does Nkarta pay dividends?

Nkarta pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nkarta?

Nkarta paid dividends every year for the past 0 years.

What is the dividend of Nkarta?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nkarta located?

Nkarta is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nkarta kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nkarta from 12/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/5/2024.

When did Nkarta pay the last dividend?

The last dividend was paid out on 12/5/2024.

What was the dividend of Nkarta in the year 2023?

In the year 2023, Nkarta distributed 0 USD as dividends.

In which currency does Nkarta pay out the dividend?

The dividends of Nkarta are distributed in USD.

Andere Kennzahlen von Nkarta

Our stock analysis for Nkarta Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nkarta Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.